With rising incidences of ischemic heart disease, the therapeutic options for its management are also increasing. Most of the patients undergo invasive treatments like percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass graft (CABG) for refractory ischemic heart disease. However, non-invasive treatments must be sought for patients with prolonged chest pain, where invasive treatments (PTCA/CABG) are not indicated. In the recent past, Extracorporeal Shockwave Myocardial Revascularization (ESMR) therapy has been proposed as an effective and safe option for refractory ischemic heart disease.
ESMR induces local angiogenesis at myocardial ischemic areas using low intensity, non-invasive and focused shockwaves. In this video, Dr. Rahul R Patil discusses ESMR as an effective non-invasive therapy for refractory CAD or angina. He further presents clinical evidence for…
